文献速递瓣膜病与结构性心脏病

三尖瓣外科与经导管治疗的未知与挑战:最新专家综述

Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review.
PubMed 文献 · Eur Heart J · 2020-01-01

三尖瓣反流(TR)常合并左心疾病,未治疗或治疗后复发与死亡率增加相关,但长期被忽视且治疗不足。外科手术是目前唯一指南I类推荐 therapy,经导管修复或置换装置正在发展中。本文综述当前证据,强调争议问题并展望未来路线图。

要点

  • 显著TR未治疗或治疗后复发与死亡率增加相关
  • 外科手术(瓣环成形、瓣叶修复或置换)是唯一指南I类推荐治疗
  • 经导管TR装置模拟外科技术,但最佳时机和技术选择尚未明确

核心结论

  • TR领域存在诸多未知,包括疾病进程、风险分层和成功治疗预测因素,最佳治疗时机和技术选择有待阐明。

研究设计与样本

  • 本文为最新专家综述,旨在突出当前证据、强调主要争议问题并提出未来路线图。

主要发现

  • TR常合并左心疾病如二尖瓣反流,显著TR未治疗或治疗后复发与死亡率增加相关。
  • TR历史上常被忽视且治疗不足,外科手术是目前唯一指南I类推荐治疗。
  • 许多模拟成熟外科技术的经导管三尖瓣修复或置换装置正在开发中。

临床怎么用

  • 外科手术(瓣环成形、瓣叶修复或瓣膜置换)是当前唯一指南I类推荐治疗。
  • 经导管装置仍在开发中,最佳治疗时机和技术选择需进一步研究。

局限性

  • TR疾病进程、手术或介入风险分层及成功治疗预测因素尚不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tricuspid regurgitation (TR) is a frequent and complex problem, commonly combined with left-sided heart disease, such as mitral regurgitation. Significant TR is associated with increased mortality if left untreated or recurrent after therapy. Tricuspid regurgitation was historically often disregarded and remained undertreated. Surgery is currently the only Class I Guideline recommended therapy for TR, in the form of annuloplasty, leaflet repair, or valve replacement. As growing experience of transcatheter therapy in structural heart disease, many dedicated transcatheter tricuspid repair or replacement devices, which mimic well-established surgical techniques, are currently under development. Nevertheless, many aspects of TR are little understood, including the disease process, surgical or interventional risk stratification, and predictors of successful therapy. The optimal treatment timing and the choice of proper surgical or interventional technique for significant TR remain to be elucidated. In this context, we aim to highlight the current evidence, underline major controversial issues in this field and present a future roadmap for TR therapy.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Chang CC, Veen KM, Hahn RT, et al. Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review. Eur Heart J. 2020. PMID: 31511897. doi:10.1093/eurheartj/ehz614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。